Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
PMC
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
GLP-1 programs the neurovascular landscape.
Cell Metab. 36, 2173-2189 (2024)
Readily available nutrient-rich foods exploit our inherent drive to overconsume, creating an environment of overnutrition. This transformative setting has led to persistent health issues, such as obesity and metabolic syndrome. The development of glucagon-like peptide-1 receptor (GLP-1R) agonists reveals our ability to pharmacologically manage weight and address metabolic conditions. Obesity is directly linked to chronic low-grade inflammation, connecting our metabolic environment to neurodegenerative diseases. GLP-1R agonism in curbing obesity, achieved by impacting appetite and addressing associated metabolic defects, is revealing additional benefits extending beyond weight loss. Whether GLP-1R agonism directly impacts brain health or does so indirectly through improved metabolic health remains to be elucidated. In exploring the intricate connection between obesity and neurological conditions, recent literature suggests that GLP-1R agonism may have the capacity to shape the neurovascular landscape. Thus, GLP-1R agonism emerges as a promising strategy for addressing the complex interplay between metabolic health and cognitive well-being.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Glp-1 ; Blood-brain Barrier ; Cerebral Blood Flow ; Cerebral Vasculature ; Cerebrospinal Fluid ; Metabolic Syndrome ; Myelination ; Neurodegeneration ; Neurovascular Coupling ; Obesity; Glucagon-like Peptide-1; Blood-brain-barrier; High-fat Diet; Focal Cerebral-ischemia; Dpp-4 Inhibitor; Hemorrhagic Transformation; Vascular-permeability; Intracranial-pressure; Cognitive Impairment; Functional Recovery
ISSN (print) / ISBN
1550-4131
e-ISSN
1932-7420
Journal
Cell Metabolism
Quellenangaben
Volume: 36,
Issue: 10,
Pages: 2173-2189
Publisher
Elsevier
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Diabetes and Obesity (IDO)
Grants
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
Interstellar Initiative (NYAS/AMED)
Matilda E. Ziegler Family Foundation
McCluskey family
National Institute of Diabetes and Digestive and Kidney Diseases
Interstellar Initiative (NYAS/AMED)
Matilda E. Ziegler Family Foundation
McCluskey family